Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy
Abstract Glioblastoma is the most aggressive and lethal cancer of the central nervous system, presenting substantial treatment challenges. The current standard treatment, which includes surgical resection followed by temozolomide and radiation, offers limited success. While immunotherapies, such as...
| Published in: | npj Precision Oncology |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Online Access: | https://doi.org/10.1038/s41698-025-00920-x |
